Target intelligence / Profile preview

Deoxyribonucleic acid and DNA-modifying enzymes (DNA, null for the group of associated enzymes (individual enzymes have abbreviations, e.g., DNA ligase, POL, PARP))

Target
DNA, null for the group of associated enzymes (individual enzymes have abbreviations, e.g., DNA ligase, POL, PARP)
Molecular classification
Nucleic acid (DNA), Enzyme (oxidoreductase, transferase, hydrolase, lyase, isomerase, ligase—includes DNA polymerases, DNA ligases, DNA repair enzymes), DNA-binding protein
01

Overview

Deoxyribonucleic acid (DNA) is the hereditary material in cells and viruses, composed of a double-stranded helix of nucleotides encoding genetic information essential for all living organisms. DNA is acted upon by a range of associated enzymes—including DNA polymerases (replication), ligases (joining/stitching of strands), topoisomerases (supercoiling management), nucleases (strand cutting), methyltransferases (epigenetic modification), and DNA repair enzymes (damage correction)—each with specialized roles in cellular homeostasis, division, and response to environmental stress. Both DNA and its associated enzymes are central to disease pathogenesis, notably in cancer, inflammation, neurodegeneration, genetic disorders, and infection, making them major therapeutic targets for drugs that either damage, protect, or modulate repair pathways. However, listing ‘DNA and associated enzymes’ together is not standard nomenclature and should typically be decomposed into individual targets for research or therapeutic applications.

Other names
DNAdeoxyribonucleic acidDNA polymerasesDNA ligasesDNA repair enzymesnucleic acid
02

Mechanism of action

Inhibition of DNA repair (sensitizes cancer cells to DNA damage, induces cell death); Induction of DNA damage (cytotoxic agents target DNA directly); Blockade of specific DNA-modifying enzymes (prevents repair, alters gene expression); Stimulation of DNA repair (therapeutic upregulation for degenerative or inflammatory diseases)

03

Biological functions

Genetic information storage and transmission (DNA)DNA replicationDNA repair (base excision repair, nucleotide excision repair, mismatch repair, homologous recombination, non-homologous end joining)Cell cycle progressionCell death (apoptosis via DNA damage)Signal transduction (via DNA repair signaling)Regulation of gene expression (epigenetic modification via associated enzymes)
04

Disease associations

Cancer (mutations and repair defects)Inflammation (via DNA repair enzyme targeting)Neurodegenerative disease (DNA damage)Infection (viral DNA manipulation, DNA repair in immune cells)Genetic diseases (mutations of repair enzymes)
05

Safety considerations

Off-target toxicity (damage to normal cells during DNA repair inhibition)Secondary malignancy (due to genomic instability)Resistance mechanisms (redundant repair pathways)Immunosuppression (of anti-inflammatory therapies)
06

Interacting drugs

PARP inhibitors (e.g., olaparib, niraparib, rucaparib, talazoparib)

5 more in the full profile.

07

Biomarkers

DNA repair enzyme expression (e.g., PARP, MTH1, OGG1)Mutation burden (for PARP inhibitor sensitivity)DNA damage response signals (γH2AX, p53 status)Microsatellite instability (MSI)

Beyond the preview

Go deeper on Deoxyribonucleic acid and DNA-modifying enzymes (DNA, null for the group of associated enzymes (individual enzymes have abbreviations, e.g., DNA ligase, POL, PARP)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deoxyribonucleic acid and DNA-modifying enzymes (DNA, null for the group of associated enzymes (individual enzymes have abbreviations, e.g., DNA ligase, POL, PARP)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call